Document Type : Original Article


1 Cardiovascular Research Center, Imam Ali Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran

2 Cardiovascular Research Center, Imam Ali Hospital, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran



INTRODUCTION: Hypertension is widely known as a significant factor in the development of cardiovascular diseases. However, there is increasing interest in the potential link between low admission systolic blood pressure (SBP) and higher mortality rates. Therefore, this study aimed to investigate the relationship between admission SBP and the probability of one-year mortality in patients with ST-segment elevation myocardial infarction (STEMI).
METHOD: This study, which used data from registries, focused on patients diagnosed with STEMI between July 2018 and December 2019. The patients were divided into three groups based on their admission SBP: normal (< 112 mm Hg), elevated (112–140 mm Hg), and hypertension (≥140 mm Hg), and were followed for one year. The researchers used Cox proportional models to analyze the data, which allowed them to estimate crude and fully adjusted hazard ratios, along with their corresponding 95% confidence intervals (HR, 95% CI).
RESULTS: This study, which included 1159 patients with a mean age of 60.71±12.19, 914 (78.86%) were male, and 108 (9.32%) died within one year. Among the patients, 276 had a normal admission SBP, 338 had elevated SBP, and 545 had hypertension. Those with hypertension had a higher-risk profile, including factors such as hyperlipidemia, BMI, LDL levels, anterior myocardial infarction, and a higher prevalence of females. The crude and fully adjusted hazard ratios (HR) for the relationship between elevated admission SBP and mortality were calculated as 0.36 (95% CI: 0.23-0.56) and 0.43 (95% CI: 0.23-0.81), respectively.
CONCLUSION: The study's findings indicate a connection between increased admission SBP and a decreased probability of one-year mortality among patients with STEMI. Unlike the general population, where there is a direct linear correlation between SBP and the risk of future cardiovascular events, this research demonstrates an inverse relationship between SBP and one-year mortality.


1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367: 1747-57.
2. Anderson JL, Morrow DA. Acute myocardial infarction. N Engl J Med 2017; 376(21): 2053-64.
3. Yusuf S, Hawken S, Ôunpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364(9438): 937-52.
4. Amar J, Chamontin B, Ferrieres J, Danchin N, Grenier O, Cantet C, et al. Hypertension control at hospital discharge after acute coronary event: influence on cardiovascular prognosis-the PREVENIR study. Heart 2002; 88(6): 587-91.
5. Bangalore S, Messerli FH, Ou F-S, Tamis-Holland J, Palazzo A, Roe MT, et al. Blood pressure paradox in patients with non-ST-segment elevation acute coronary syndromes: Results from 139,194 patients in the Can Rapid risk stratification of Unstable angina patients Suppress A Dverse outcomes with Early implementation of the American College of Cardiology/American Heart Association Guidelines (CRUSADE) quality improvement initiative. Am Heart J 2009; 157(3): 525-31.
6. Gheorghiade M, Abraham WT, Albert NM, Greenberg BH, O’Connor CM, She L, et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA 2006; 296(18): 2217-26.
7. Huang X, Liu J, Hu S, Zhang L, Miao F, Tian A, et al. Systolic blood pressure at admission and long-term clinical outcomes in patients hospitalized for heart failure. ESC Heart Fail 2021; 8(5): 4007-17.
8. Buiciuc O, Rusinaru D, Lévy F, Peltier M, Slama M, Leborgne L, et al. Low systolic blood pressure at admission predicts long-term mortality in heart failure with preserved ejection fraction. J Card Fail 2011; 17(11): 907-15.
9. Flack JM, Adekola B. Blood pressure and the new ACC/AHA hypertension guidelines. Trends Cardiovasc Med 2020; 30(3): 160-4.
10. Cuschieri S. The STROBE guidelines. Saudi J Anaesth 2019; 13(Suppl 1): S31.
11. Huang B, Yang Y, Zhu J, Liang Y, Tan H. Clinical characteristics and short-term outcomes in patients with elevated admission systolic blood pressure after acute ST-elevation myocardial infarction: a population-based study. BMJ Open 2014; 4(6): e005097.
12. Güder G, Frantz S, Bauersachs J, Allolio B, Wanner C, Koller MT, et al. Reverse epidemiology in systolic and nonsystolic heart failure: cumulative prognostic benefit of classical cardiovascular risk factors. Circ Heart Fail 2009; 2(6): 563-71.
13. Vidán MT, Bueno H, Wang Y, Schreiner G, Ross JS, Chen J, et al. The ‎relationship between systolic blood pressure on admission and mortality in older patients with heart failure. Eur J Heart Fail 2010; 12(2): 148-55.
14. Pérez-Calvo J, Montero-Pérez-Barquero M, Camafort-Babkowski M, Conthe-Gutiérrez P, Formiga F, Aramburu-Bodas O, et al. Influence of admission blood pressure on mortality in patients with acute decompensated heart failure. QJM 2011; 104(4): 325-33.
15. Yancy CW, Lopatin M, Stevenson LW, De Marco T, Fonarow GC, Committee ASA, et al. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol 2006; 47(1): 76-84.
16. Raphael CE, Whinnett ZI, Davies J, Fontana M, Ferenczi E, Manisty CH, et al. Quantifying the paradoxical effect of higher systolic blood pressure on mortality in chronic heart failure. Heart 2009; 95(1): 56-62.
17. Rouleau JL, Roecker EB, Tendera M, Mohacsi P, Krum H, Katus HA, et al. Influence of pretreatment systolic blood pressure on the effect of carvedilol ‎in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study. J Am Coll Cardiol 2004; 43(8): 1423-9.
18.  Jennrich R. Age-specific relevance of usual blood pressure to vascular mortality. Lancet 2003; 361(9366): 1390-1.
19. Barsheshet A, Gottlieb S, Goldenberg I. Admission systolic blood pressure predicts mortality differently in elderly and young patients hospitalized with acute heart failure. Eur J Heart Fail 2010; 12(7): 763-4.
20. Kang DG, Jeong MH, Ahn Y, Chae SC, Hur SH, Hong TJ, et al. Clinical effects of hypertension on the mortality of patients with acute myocardial infarction. J Korean Med Sci 2009; 24(5): 800-6.
21. Majahalme SK, Smith DE, Cooper JV, Kline-Rogers E, Mehta RH, Eagle KA, et al. Comparison of patients with acute coronary syndrome with and without systemic hypertension. Am J Cardiol 2003; 92(3): 258-63. 
22. Ali I, Akman D, Bruun NE, Køber L, Brendorp B, Ottesen M, et al. Importance of a history of hypertension for the prognosis after acute myocardial infarction for the bucindolol evaluation in acute myocardial infarction trial (BEAT) study group. Clin Cardiol 2004; 27(5): 265-9.
23. Huang X, Liu J, Hu S, Zhang L, Miao F, Tian A, et al. Systolic blood pressure at admission and long‐term clinical outcomes in patients hospitalized for heart failure. ESC Heart Fail 2021; 8(5): 4007-17.